Ledyard National Bank Has $8.87 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Ledyard National Bank lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,540 shares of the healthcare conglomerate’s stock after buying an additional 873 shares during the quarter. Ledyard National Bank’s holdings in UnitedHealth Group were worth $8,873,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Glassy Mountain Advisors Inc. increased its stake in shares of UnitedHealth Group by 3.4% in the 4th quarter. Glassy Mountain Advisors Inc. now owns 8,307 shares of the healthcare conglomerate’s stock valued at $4,202,000 after acquiring an additional 273 shares during the last quarter. Telos Capital Management Inc. raised its holdings in UnitedHealth Group by 0.7% in the fourth quarter. Telos Capital Management Inc. now owns 14,309 shares of the healthcare conglomerate’s stock worth $7,238,000 after purchasing an additional 102 shares during the period. GHP Investment Advisors Inc. increased its position in shares of UnitedHealth Group by 2.3% in the 4th quarter. GHP Investment Advisors Inc. now owns 17,433 shares of the healthcare conglomerate’s stock valued at $8,819,000 after buying an additional 387 shares in the last quarter. Oakworth Capital Inc. grew its stake in UnitedHealth Group by 8.5% in the fourth quarter. Oakworth Capital Inc. now owns 4,835 shares of the healthcare conglomerate’s stock valued at $2,446,000 after acquiring an additional 377 shares during the period. Finally, Buck Wealth Strategies LLC raised its position in shares of UnitedHealth Group by 29.3% during the fourth quarter. Buck Wealth Strategies LLC now owns 15,747 shares of the healthcare conglomerate’s stock worth $7,966,000 after purchasing an additional 3,571 shares during the period. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Stephens increased their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Morgan Stanley dropped their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Price Performance

NYSE:UNH opened at $529.71 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market cap of $487.48 billion, a P/E ratio of 34.17, a P/E/G ratio of 1.48 and a beta of 0.61. The firm’s fifty day moving average price is $532.43 and its two-hundred day moving average price is $564.77. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the company earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities analysts expect that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.